Main Topic: In this episode of Oncology Unscripted, Dr Marshall explores how cancer innovations—from immune-based therapies to novel prognostics—are redefining what’s possible in oncology. But innovation alone isn’t enough. How do we balance excitement over breakthrough data with the real-world challenge of access, affordability, and practical application? This episode asks what smarter cancer care really looks like—and who gets to experience it. Interview: ASCO 2025 brought forward breakthrough data and paradigm-shifting therapies—but access to these innovations remains painfully unequal across the globe. In part 1 of this special Candid Conversations series, Dr John Marshall sits down with an international leader in oncology—Dr David Kerr, based in the UK, to examine how cost, policy, and infrastructure determine who actually receives cutting-edge cancer care. MedBuzz: From the U.S. to around the globe, access to cancer care is far from equal. In this episode, Dr John Marshall explores how innovation outpaces delivery—from political debates over Medicaid and drug pricing at home to the challenges of quality, cost, and equity abroad. As cancer breakthroughs emerge, who actually gets the benefit—and who gets left behind?